Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Ifosfamide × Clear all

Phase

Status

Completed 8 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Penile Neoplasms 2 Osteosarcoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Burkitt Lymphoma 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pleuropulmonary blastoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasm Metastasis 1 Myoepithelioma 1 Lymphoma, Follicular 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

venetoclax 19 Cyclophosphamide 17 pembrolizumab 15 Dexamethasone 14 Cytarabine 12 fludarabine 11 Azacitidine 10 Gemcitabine 9 pomalidomide 7 Rituximab 7 Carboplatin 7 selinexor 6 glofitamab 6 Temozolomide 6 Lenalidomide 6 Granulocyte Colony-Stimulating Factor 6 fludarabine phosphate 5 Paclitaxel 5 Oxaliplatin 5 Injections 5 Cisplatin 5 zanubrutinib 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 carfilzomib 4 Surgical Procedures, Operative 4 Nivolumab 4 Decitabine 4 Cladribine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05533775 2026-03-06

iMATRIX GLO

Hoffmann-La Roche

Phase 1/2 Recruiting

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡